436 related articles for article (PubMed ID: 29429051)
1. Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.
Hedya SA; Safar MM; Bahgat AK
Mol Neurobiol; 2018 Sep; 55(9):7579-7587. PubMed ID: 29429051
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine antiparkinsonian potential: Nurr1 modulation versus autophagy inhibition.
Hedya SA; Safar MM; Bahgat AK
Behav Brain Res; 2019 Jun; 365():82-88. PubMed ID: 30797853
[TBL] [Abstract][Full Text] [Related]
3. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1141-1150. PubMed ID: 31408200
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.
Abdelsalam RM; Safar MM
J Neurochem; 2015 Jun; 133(5):700-7. PubMed ID: 25752913
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.
El-Abhar H; Abd El Fattah MA; Wadie W; El-Tanbouly DM
PLoS One; 2018; 13(9):e0203837. PubMed ID: 30260985
[TBL] [Abstract][Full Text] [Related]
7. Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
Zhang L; Cen L; Qu S; Wei L; Mo M; Feng J; Sun C; Xiao Y; Luo Q; Li S; Yang X; Xu P
PLoS One; 2016; 11(4):e0152931. PubMed ID: 27045591
[TBL] [Abstract][Full Text] [Related]
8. Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson's Disease Rat Model.
Arab HH; Safar MM; Shahin NN
ACS Chem Neurosci; 2021 Feb; 12(4):689-703. PubMed ID: 33543924
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway.
Mohamad KA; El-Naga RN; Wahdan SA
Toxicol Appl Pharmacol; 2022 Jan; 435():115853. PubMed ID: 34973289
[TBL] [Abstract][Full Text] [Related]
10. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of endoplasmic reticulum stress-activated IRE1α-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease.
Tong Q; Wu L; Jiang T; Ou Z; Zhang Y; Zhu D
Eur J Pharmacol; 2016 Apr; 776():106-15. PubMed ID: 26879867
[TBL] [Abstract][Full Text] [Related]
12. Corydaline alleviates Parkinson's disease by regulating autophagy and GSK-3β phosphorylation.
Zhou K; Xu S
Psychopharmacology (Berl); 2024 May; 241(5):1027-1036. PubMed ID: 38289512
[TBL] [Abstract][Full Text] [Related]
13. Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson's disease therapy.
Zaitone SA; Ahmed E; Elsherbiny NM; Mehanna ET; El-Kherbetawy MK; ElSayed MH; Alshareef DM; Moustafa YM
Pharmacol Rep; 2019 Feb; 71(1):32-41. PubMed ID: 30368226
[TBL] [Abstract][Full Text] [Related]
14. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models.
Liu J; Liu W; Lu Y; Tian H; Duan C; Lu L; Gao G; Wu X; Wang X; Yang H
Autophagy; 2018; 14(5):845-861. PubMed ID: 29433359
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico& in vivo anti-Parkinson's disease study.
Kamal RE; Menze E; Albohy A; Ahmed HI; Azab SS
Eur J Pharmacol; 2022 Oct; 932():175204. PubMed ID: 35964655
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K/Akt/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221.
Salama RM; Abdel-Latif GA; Abbas SS; El Magdoub HM; Schaalan MF
Neuropharmacology; 2020 Mar; 164():107900. PubMed ID: 31811872
[TBL] [Abstract][Full Text] [Related]
17. The Protective Effect of Korean Red Ginseng Against Rotenone-Induced Parkinson's Disease in Rat Model: Modulation of Nuclear Factor-κβ and Caspase-3.
Zaafan MA; Abdelhamid AM; Ibrahim SM
Curr Pharm Biotechnol; 2019; 20(7):588-594. PubMed ID: 31198107
[TBL] [Abstract][Full Text] [Related]
18. High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
Guttuso T
Med Hypotheses; 2019 Oct; 131():109302. PubMed ID: 31443765
[TBL] [Abstract][Full Text] [Related]
19. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease.
Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N
J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson's Disease: Modulation of Mitochondrial Perturbations.
Abdelkader NF; Safar MM; Salem HA
Mol Neurobiol; 2016 Mar; 53(2):810-817. PubMed ID: 25502462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
